FDA NDC Directory · JSON-LD · Markdown

VIDAZA

NDC 59572-102 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameazacitidine
Labeler / ManufacturerCelgene Corporation
Marketing categoryNew Drug Application (innovator) · App NDA050794
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsAZACITIDINE (100 mg/1)
Marketing started20040705
Package count1

External sources

Source: openFDA. Public-domain (CC0).